HELP     Sign In
Search

Relevance to Autism

A total of three de novo loss-of-function (LoF) variants in the ANK2 gene have been identified in ASD probands from the Simons Simplex Collection (PMIDs 22542183, 24267886, 25363768), while a fourth de novo LoF in this gene was identified in an ASD proband from the Autism Sequencing Consortium in De Rubeis et al., 2014 (PMID 25363760). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) in De Rubeis et al., 2014 identified ANK2 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). A two-stage analysis of rare de novo and inherited coding variants in 42,607 ASD cases, including 35,130 new cases from the SPARK cohort, in Zhou et al., 2022 identified ANK2 as a gene reaching exome-wide significance (P < 2.5E-06).

Molecular Function

This gene encodes a member of the ankyrin family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton. This gene is associated with Long QT syndrome 4 (LQT4) [MIM:600919], a heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
De novo gene disruptions in children on the autistic spectrum.
ASD
Support
Whole-genome sequencing of quartet families with autism spectrum disorder.
ASD
Support
ASD, epilepsy/seizures
Support
Targeted sequencing and functional analysis reveal brain-size-related genes and their networks in autism spectrum disorders.
ASD
Support
Prevalence and phenotypic impact of rare potentially damaging variants in autism spectrum disorder
ASD
Support
Large-scale discovery of novel genetic causes of developmental disorders.
Unknown diagnosis
Support
ASD, DD, ID
Support
Genomic diagnosis for children with intellectual disability and/or developmental delay.
ASD, ID
Support
ASD
ADHD, BPD, OCD, ID, learning disability
Support
Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders
ASD, DD
ID
Support
The contribution of de novo coding mutations to autism spectrum disorder
ASD
Support
Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder
ASD
Support
Rare genetic susceptibility variants assessment in autism spectrum disorder: detection rate and practical use.
ASD
Support
Epilepsy/seizures
Support
De novo genic mutations among a Chinese autism spectrum disorder cohort.
ASD
Support
Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism
ASD
Support
Integrating de novo and inherited variants in 42
ASD
Support
Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci.
ASD
Support
ASD, epilepsy/seizures
Support
Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes
ASD
Support
Autism-associated ANK2 regulates embryonic neurodevelopment
ASD
Support
Excess of rare, inherited truncating mutations in autism.
ASD
Support
Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model.
ASD
Support
Giant ankyrin-B mediates transduction of axon guidance and collateral branch pruning factor sema 3A
ASD
Recent Recommendation
Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism.
ASD
Recent Recommendation
ASD
Recent Recommendation
DD, ID, epilepsy/seizures
ASD, ADHD
Recent Recommendation
ASD
Recent Recommendation
Low load for disruptive mutations in autism genes and their biased transmission.
ASD
Recent Recommendation
Synaptic, transcriptional and chromatin genes disrupted in autism.
ASD

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN587R001 
 stop_gained 
 c.2683C>T 
 p.Arg895Ter 
 De novo 
  
 Simplex 
 GEN587R002 
 stop_gained 
 c.2968C>T 
 p.Arg990Ter 
 De novo 
  
 Simplex 
 GEN587R003 
 missense_variant 
 c.11717G>A 
 p.Arg3906Gln 
 Familial 
 Maternal 
 Multiplex 
 GEN587R004 
 frameshift_variant 
 c.7826del 
 p.Asp2610TfsTer23 
 De novo 
  
 Simplex 
 GEN587R005 
 stop_gained 
 c.3262C>T 
 p.Arg1088Ter 
 De novo 
  
 Simplex 
 GEN587R006 
 missense_variant 
 c.2421C>G 
 p.Ile807Met 
 De novo 
  
 Simplex 
 GEN587R007 
 missense_variant 
 c.4139C>G 
 p.Pro1380Arg 
 De novo 
  
 Simplex 
 GEN587R008 
 frameshift_variant 
 c.4399+5075del 
  
 Familial 
 Maternal 
 Simplex 
 GEN587R009 
 stop_gained 
 c.2620C>T 
 p.Arg874Ter 
 Familial 
 Paternal 
 Simplex 
 GEN587R010 
 missense_variant 
 c.899G>A 
 p.Arg300Gln 
 Familial 
 Maternal 
 Simplex 
 GEN587R011 
 missense_variant 
 c.3173G>A 
 p.Ser1058Asn 
 Familial 
 Maternal 
 Multiplex 
 GEN587R012 
 missense_variant 
 c.3904G>A 
 p.Val1302Ile 
 Familial 
 Paternal 
 Simplex 
 GEN587R013 
 missense_variant 
 c.4400-2382G>A 
  
 Familial 
 Maternal 
 Simplex 
 GEN587R014 
 missense_variant 
 c.4565T>A 
 p.Leu1522Gln 
 Familial 
 Paternal 
 Simplex 
 GEN587R015 
 missense_variant 
 c.4837G>A 
 p.Glu1613Lys 
 Familial 
 Paternal 
 Simplex 
 GEN587R016 
 missense_variant 
 c.5173G>A 
 p.Glu1725Lys 
 Familial 
 Paternal 
 Simplex 
 GEN587R017 
 missense_variant 
 c.5243G>A 
 p.Arg1748Gln 
 Familial 
 Paternal 
 Simplex 
 GEN587R018 
 missense_variant 
 c.4400-2044A>C 
  
 Familial 
 Maternal 
 Simplex 
 GEN587R019 
 missense_variant 
 c.5443T>C 
 p.Ser1815Pro 
 Familial 
 Paternal 
 Simplex 
 GEN587R020 
 missense_variant 
 c.5446T>C 
 p.Ser1816Pro 
 Familial 
 Maternal 
 Simplex 
 GEN587R021 
 missense_variant 
 c.1315A>G 
 p.Thr439Ala 
 Familial 
 Maternal 
 Simplex 
 GEN587R022 
 missense_variant 
 c.1912T>A 
 p.Thr638Ala 
 Familial 
 Paternal 
 Simplex 
 GEN587R023 
 missense_variant 
 c.9086A>G 
 p.Gln3029Arg 
 Familial 
 Paternal 
 Simplex 
 GEN587R024 
 missense_variant 
 c.4579C>G 
 p.Leu1527Val 
 Familial 
 Maternal 
 Multiplex 
 GEN587R025 
 missense_variant 
 c.1073G>T 
 p.Arg358Leu 
 Familial 
 Paternal 
 Simplex 
 GEN587R026 
 missense_variant 
 c.4204C>T 
 p.Leu1402Phe 
 Familial 
 Paternal 
 Simplex 
 GEN587R027 
 missense_variant 
 c.4399+3627C>T 
  
 Familial 
 Maternal 
 Simplex 
 GEN587R028 
 missense_variant 
 c.4399+3921C>T 
  
 Familial 
 Maternal 
 Simplex 
 GEN587R029 
 missense_variant 
 c.5552C>T 
 p.Thr1851Ile 
 Familial 
 Paternal 
 Simplex 
 GEN587R030 
 stop_gained 
 c.2599C>T 
 p.Arg867Ter 
 Unknown 
  
 Unknown 
 GEN587R031 
 stop_gained 
 c.2944C>T 
 p.Arg982Ter 
 Unknown 
  
 Unknown 
 GEN587R032 
 splice_site_variant 
 c.3198-1G>A 
  
 Unknown 
  
 Unknown 
 GEN587R033 
 missense_variant 
 c.3268A>C 
 p.Ser1090Arg 
 Unknown 
  
 Unknown 
 GEN587R034 
 missense_variant 
 c.4049C>T 
 p.Thr1350Ile 
 Unknown 
  
 Unknown 
 GEN587R035 
 missense_variant 
 c.4399+2924G>T 
  
 Unknown 
  
 Unknown 
 GEN587R036 
 missense_variant 
 c.4399+3113C>T 
  
 Unknown 
  
 Unknown 
 GEN587R037 
 missense_variant 
 c.4399+5003G>A 
  
 Unknown 
  
 Unknown 
 GEN587R038 
 missense_variant 
 c.883A>C 
 p.Lys295Gln 
 Unknown 
  
 Unknown 
 GEN587R039 
 missense_variant 
 G>A 
 p.Asn3521Tyr 
 Unknown 
  
 Unknown 
 GEN587R040 
 missense_variant 
 c.5243G>A 
 p.Arg1748Gln 
 Unknown 
  
 Unknown 
 GEN587R041 
 missense_variant 
 c.166G>A 
 p.Asp56Asn 
 Unknown 
  
 Unknown 
 GEN587R042 
 missense_variant 
 c.899G>A 
 p.Arg300Gln 
 Unknown 
  
 Unknown 
 GEN587R043 
 missense_variant 
 c.2104G>A 
 p.Ala702Thr 
 Unknown 
  
 Unknown 
 GEN587R044 
 missense_variant 
 c.3047G>A 
 p.Gly1016Asp 
 Unknown 
  
 Unknown 
 GEN587R045 
 missense_variant 
 c.3128C>A 
 p.Pro1043Gln 
 Unknown 
  
 Unknown 
 GEN587R046 
 missense_variant 
 c.3959A>G 
 p.Glu1320Gly 
 Unknown 
  
 Unknown 
 GEN587R047 
 missense_variant 
 c.4399+5010C>T 
  
 Unknown 
  
 Unknown 
 GEN587R048 
 missense_variant 
 c.5392G>A 
 p.Gly1798Arg 
 Unknown 
  
 Unknown 
 GEN587R049 
 missense_variant 
 c.2945G>A 
 p.Arg982Gln 
 Unknown 
  
 Unknown 
 GEN587R050 
 missense_variant 
 c.3539A>G 
 p.Gln1180Arg 
 Unknown 
  
 Unknown 
 GEN587R051 
 missense_variant 
 c.7228G>C 
 p.Glu2410Gln 
 Unknown 
  
 Unknown 
 GEN587R052 
 missense_variant 
 c.9284C>T 
 p.Thr3095Ile 
 Unknown 
  
 Unknown 
 GEN587R053 
 missense_variant 
 c.9298C>A 
 p.Pro3100Thr 
 Unknown 
  
 Unknown 
 GEN587R054 
 missense_variant 
 c.11807A>G 
 p.Tyr3936Cys 
 Unknown 
  
 Unknown 
 GEN587R055 
 missense_variant 
 c.3320A>G 
 p.Glu1107Gly 
 De novo 
  
 Unknown 
 GEN587R056 
 missense_variant 
 c.10286A>T 
 p.Glu3429Val 
 De novo 
  
 Multiplex 
 GEN587R057 
 missense_variant 
 c.5530C>T 
 p.Pro1844Ser 
 De novo 
  
 Simplex 
 GEN587R058 
 missense_variant 
 c.1118C>T 
 p.Ala373Val 
 Familial 
 Maternal 
  
 GEN587R059 
 missense_variant 
 c.2930G>A 
 p.Arg977Gln 
 Familial 
 Maternal 
  
 GEN587R060 
 frameshift_variant 
 c.8797del 
 p.Ser2933ProfsTer40 
 Unknown 
 Not maternal 
  
 GEN587R061 
 missense_variant 
 c.11650G>A 
 p.Glu3884Lys 
 Unknown 
 Not maternal 
  
 GEN587R062 
 missense_variant 
 c.11683G>A 
 p.Val3895Met 
 Familial 
 Paternal 
  
 GEN587R063 
 missense_variant 
 c.9055A>G 
 p.Met3019Val 
 De novo 
  
 Simplex 
 GEN587R064 
 stop_gained 
 c.5207C>G 
 p.Ser1736Ter 
 Unknown 
  
 Multiplex 
 GEN587R065 
 frameshift_variant 
 c.4399+3133del 
  
 De novo 
  
  
 GEN587R066 
 missense_variant 
 c.5329G>C 
 p.Val1777Leu 
 De novo 
  
 Simplex 
 GEN587R067 
 missense_variant 
 c.10645C>T 
 p.Arg3549Cys 
 Familial 
  
 Simplex 
 GEN587R068 
 missense_variant 
 c.7999G>A 
 p.Glu2667Lys 
 Familial 
  
 Simplex 
 GEN587R069 
 missense_variant 
 c.9173G>T 
 p.Arg3058Leu 
 Familial 
  
 Simplex 
 GEN587R070 
 missense_variant 
 c.9856G>A 
 p.Glu3286Lys 
 Familial 
  
 Simplex 
 GEN587R071 
 stop_gained 
 c.3007C>T 
 p.Arg1003Ter 
 De novo 
  
 Simplex 
 GEN587R072 
 missense_variant 
 c.11650G>A 
 p.Glu3884Lys 
 Familial 
 Maternal 
 Simplex 
 GEN587R073 
 missense_variant 
 c.1103C>G 
 p.Ala368Gly 
 Familial 
 Maternal 
 Simplex 
 GEN587R074 
 missense_variant 
 c.2455G>A 
 p.Glu819Lys 
 Familial 
 Paternal 
 Simplex 
 GEN587R075 
 missense_variant 
 c.1574C>T 
 p.Ala525Val 
 Familial 
 Maternal 
 Simplex 
 GEN587R076 
 synonymous_variant 
 c.3339C>T 
 p.Asn1113= 
 De novo 
  
  
 GEN587R077 
 missense_variant 
 c.1088T>G 
 p.Leu363Arg 
 De novo 
  
 Simplex 
 GEN587R078 
 synonymous_variant 
 c.4293G>A 
 p.Leu1431= 
 De novo 
  
 Simplex 
 GEN587R079 
 stop_gained 
 c.9184G>T 
 p.Glu3062Ter 
 De novo 
  
 Simplex 
 GEN587R080 
 frameshift_variant 
 c.1961_1967del 
 p.Thr654ArgfsTer32 
 De novo 
  
  
 GEN587R081 
 frameshift_variant 
 c.4399+3148del 
  
 De novo 
  
  
 GEN587R082 
 frameshift_variant 
 c.4400-1628_4400-1627dup 
  
 De novo 
  
  
 GEN587R083 
 frameshift_variant 
 c.6853_6857del 
 p.Ile2285TrpfsTer4 
 Familial 
 Maternal 
  
 GEN587R084 
 splice_site_variant 
 c.5412+2T>C 
  
 Familial 
 Paternal 
 Simplex 
 GEN587R085 
 stop_gained 
 c.*76A>T 
  
 Familial 
 Paternal 
  
 GEN587R086 
 frameshift_variant 
 c.4399+4052del 
  
 Unknown 
  
  
 GEN587R087 
 frameshift_variant 
 c.11241_11245del 
 p.Glu3747AspfsTer14 
 Unknown 
  
  
 GEN587R088 
 stop_gained 
 c.4252C>T 
 p.Arg1418Ter 
 Unknown 
  
  
 GEN587R089 
 stop_gained 
 c.3103C>T 
 p.Pro1035Ser 
 Unknown 
  
  
 GEN587R090 
 missense_variant 
 c.898C>T 
 p.Arg300Trp 
 Familial 
 Maternal 
  
 GEN587R091 
 missense_variant 
 c.814G>A 
 p.Asp272Asn 
 Familial 
 Maternal 
  
 GEN587R092 
 missense_variant 
 c.2218G>C 
 p.Gly740Arg 
 Familial 
 Maternal 
  
 GEN587R093 
 missense_variant 
 c.3865A>T 
 p.Arg1289Trp 
 Familial 
 Maternal 
  
 GEN587R094 
 missense_variant 
 c.4243C>A 
 p.Pro1415Thr 
 Familial 
 Maternal 
  
 GEN587R095 
 missense_variant 
 c.4400-3032G>T 
  
 Familial 
 Maternal 
  
 GEN587R096 
 missense_variant 
 c.5368G>A 
 p.Glu1790Lys 
 Familial 
 Maternal 
  
 GEN587R097 
 missense_variant 
 c.2000T>A 
 p.Ile667Asn 
 Familial 
 Maternal 
  
 GEN587R098 
 missense_variant 
 c.2000T>A 
 p.Ile667Asn 
 Familial 
 Paternal 
  
 GEN587R099 
 missense_variant 
 c.10804G>A 
 XP_005262998.1:p.Glu3602Lys 
 Familial 
 Maternal 
  
 GEN587R100 
 missense_variant 
 c.5434C>T 
 p.Arg1812Trp 
 Familial 
 Maternal 
  
 GEN587R101 
 missense_variant 
 c.5434C>T 
 p.Arg1812Trp 
 Familial 
 Paternal 
  
 GEN587R102 
 missense_variant 
 c.9952G>A 
 XP_005262998.1:p.Glu3318Lys 
 Familial 
 Maternal 
  
 GEN587R103 
 missense_variant 
 c.4400-2349G>A 
  
 Familial 
 Paternal 
  
 GEN587R104 
 missense_variant 
 c.4400-4206G>A 
  
 Familial 
 Paternal 
  
 GEN587R105 
 missense_variant 
 c.4400-1560C>T 
  
 Familial 
 Paternal 
  
 GEN587R106 
 missense_variant 
 c.5351C>A 
 p.Pro1784His 
 Familial 
 Paternal 
  
 GEN587R107 
 missense_variant 
 c.1205C>T 
 p.Ser402Leu 
 Familial 
 Paternal 
  
 GEN587R108 
 missense_variant 
 c.688C>A 
 p.Leu230Ile 
 Unknown 
  
  
 GEN587R109 
 missense_variant 
 c.1831C>T 
 p.Pro611Ser 
 Unknown 
  
  
 GEN587R110 
 missense_variant 
 c.1247T>G 
 p.Leu416Arg 
 Unknown 
  
 Simplex 
 GEN587R111 
 missense_variant 
 c.1448C>T 
 p.Ala483Val 
 Unknown 
  
  
 GEN587R112 
 missense_variant 
 c.3163G>A 
 p.Glu1055Lys 
 Unknown 
  
  
 GEN587R113 
 missense_variant 
 c.3550C>A 
 p.Arg1184Ser 
 Unknown 
  
  
 GEN587R114 
 missense_variant 
 c.3914C>T 
 p.Ala1305Val 
 Unknown 
  
  
 GEN587R115 
 missense_variant 
 c.4400-3059G>A 
  
 Unknown 
  
  
 GEN587R116 
 missense_variant 
 c.5543G>C 
 p.Arg1848Pro 
 Unknown 
  
  
 GEN587R117 
 missense_variant 
 c.4399+4175C>T 
  
 Unknown 
  
  
 GEN587R118 
 missense_variant 
 c.4399+4175C>T 
  
 Unknown 
  
  
 GEN587R119 
 missense_variant 
 c.4400-3311C>T 
  
 Unknown 
  
  
 GEN587R120 
 missense_variant 
 c.8894C>T 
 p.Thr2965Ile 
 Unknown 
  
  
 GEN587R121 
 missense_variant 
 c.679G>A 
 p.Val227Met 
 Unknown 
  
 Simplex 
 GEN587R122 
 missense_variant 
 c.3265C>T 
 p.Arg1089Cys 
 Unknown 
  
  
 GEN587R123 
 missense_variant 
 c.4400-3033C>T 
  
 Unknown 
  
  
 GEN587R124 
 missense_variant 
 c.2203G>A 
 p.Ala735Thr 
 Unknown 
  
  
 GEN587R125 
 missense_variant 
 c.4426G>A 
 p.Glu1476Lys 
 Unknown 
  
  
 GEN587R126 
 missense_variant 
 c.5434C>T 
 p.Arg1812Trp 
 Unknown 
  
  
 GEN587R127 
 missense_variant 
 c.4400-2349G>A 
  
 Unknown 
  
  
 GEN587R128 
 missense_variant 
 c.1268C>T 
 p.Ser423Leu 
 Unknown 
  
  
 GEN587R129 
 missense_variant 
 c.257G>A 
 p.Arg86Lys 
 Unknown 
  
  
 GEN587R130 
 missense_variant 
 c.1514C>T 
 p.Ala505Val 
 Unknown 
  
  
 GEN587R131 
 missense_variant 
 c.1871C>T 
 p.Ala624Val 
 Unknown 
  
  
 GEN587R132 
 missense_variant 
 c.2959C>T 
 p.Arg987Trp 
 Unknown 
  
  
 GEN587R133 
 missense_variant 
 c.4180T>A 
 p.Phe1394Ile 
 Unknown 
  
  
 GEN587R134 
 missense_variant 
 c.10798C>G 
 p.Gln3600Glu 
 Unknown 
  
  
 GEN587R135 
 missense_variant 
 c.5401G>A 
 p.Val1801Met 
 Unknown 
  
  
 GEN587R136 
 missense_variant 
 c.3886C>G 
 p.Arg1296Gly 
 Unknown 
  
  
 GEN587R137 
 missense_variant 
 c.3065G>A 
 XP_005262998.1:p.Arg1022Gln 
 Unknown 
 Not paternal 
  
 GEN587R138 
 frameshift_variant 
 c.4400-3319del 
  
 Familial 
 Maternal 
  
 GEN587R139 
 frameshift_variant 
 c.5683del 
 p.Ser1895LeufsTer99 
 Unknown 
  
  
 GEN587R140 
 stop_gained 
 c.4400-4143C>T 
  
 Unknown 
  
  
 GEN587R141 
 frameshift_variant 
 c.2121del 
 p.Val708Ter 
 Unknown 
  
  
 GEN587R142 
 frameshift_variant 
 c.10463del 
 p.Leu3488Ter 
 Unknown 
  
  
 GEN587R143 
 frameshift_variant 
 c.11003_11006del 
 p.Glu3668GlyfsTer106 
 Unknown 
  
  
 GEN587R144 
 stop_gained 
 c.2941C>T 
 p.Arg981Ter 
 Unknown 
  
  
 GEN587R145 
 stop_gained 
 c.4400-4494G>T 
  
 Unknown 
  
  
 GEN587R146 
 stop_gained 
 c.*35C>T 
  
 Unknown 
  
  
 GEN587R147 
 missense_variant 
 c.4399+4113C>T 
  
 Unknown 
  
  
 GEN587R148 
 missense_variant 
 c.4399+4113C>T 
  
 Unknown 
  
  
 GEN587R149 
 missense_variant 
 c.4247G>T 
 p.Cys1416Phe 
 Unknown 
  
  
 GEN587R150 
 missense_variant 
 c.1991C>T 
 p.Thr664Ile 
 Unknown 
  
  
 GEN587R151 
 missense_variant 
 c.4400-3032G>A 
  
 Unknown 
  
  
 GEN587R152 
 missense_variant 
 c.4625G>A 
 p.Cys1542Tyr 
 Unknown 
  
  
 GEN587R153 
 missense_variant 
 c.5543G>C 
 p.Arg1848Pro 
 Unknown 
  
  
 GEN587R154 
 missense_variant 
 c.1943C>T 
 p.Ala648Val 
 Unknown 
  
  
 GEN587R155 
 missense_variant 
 c.2006C>T 
 p.Ala669Val 
 Unknown 
  
  
 GEN587R156 
 missense_variant 
 c.2773C>T 
 p.Arg925Cys 
 Unknown 
  
  
 GEN587R157 
 missense_variant 
 c.1552C>T 
 p.Arg518Trp 
 Unknown 
  
  
 GEN587R158 
 missense_variant 
 c.2918G>A 
 p.Arg973Gln 
 Unknown 
  
  
 GEN587R159 
 missense_variant 
 c.3545G>A 
 p.Arg1182Gln 
 Unknown 
  
  
 GEN587R160 
 missense_variant 
 c.1774C>A 
 p.Leu592Met 
 Unknown 
  
  
 GEN587R161 
 missense_variant 
 c.3083G>A 
 p.Ser1028Asn 
 Unknown 
  
  
 GEN587R162 
 missense_variant 
 c.2203G>A 
 p.Ala735Thr 
 Unknown 
  
  
 GEN587R163 
 missense_variant 
 c.4112C>T 
 XP_005262998.1:p.Pro1371Leu 
 Unknown 
  
  
 GEN587R164 
 missense_variant 
 c.3989C>T 
 p.Pro1330Leu 
 Unknown 
  
  
 GEN587R165 
 missense_variant 
 c.3989C>T 
 p.Pro1330Leu 
 Unknown 
  
  
 GEN587R166 
 missense_variant 
 c.4426G>A 
 p.Glu1476Lys 
 Unknown 
  
  
 GEN587R167 
 missense_variant 
 c.899G>A 
 p.Arg300Gln 
 Unknown 
  
  
 GEN587R168 
 missense_variant 
 c.11800G>A 
 p.Asp3934Asn 
 Unknown 
  
  
 GEN587R169 
 missense_variant 
 c.1297G>A 
 p.Gly433Arg 
 Unknown 
  
  
 GEN587R170 
 missense_variant 
 c.1297G>A 
 p.Gly433Arg 
 Unknown 
  
  
 GEN587R171 
 missense_variant 
 c.2942G>A 
 p.Arg981Gln 
 Unknown 
  
  
 GEN587R172 
 missense_variant 
 c.2942G>A 
 p.Arg981Gln 
 Unknown 
  
  
 GEN587R173 
 missense_variant 
 c.3005G>A 
 p.Arg1002His 
 Unknown 
  
  
 GEN587R174 
 missense_variant 
 c.3005G>A 
 p.Arg1002His 
 Unknown 
  
  
 GEN587R175 
 missense_variant 
 c.2773C>T 
 p.Arg925Cys 
 Unknown 
  
  
 GEN587R176 
 splice_site_variant 
 c.2799-1G>A 
  
 Unknown 
  
  
 GEN587R177 
 stop_gained 
 c.6055C>T 
 p.Gln2019Ter 
 De novo 
  
  
 GEN587R178 
 splice_region_variant 
 c.1288-5C>T 
  
 De novo 
  
  
 GEN587R179 
 missense_variant 
 c.1517G>A 
 p.Arg506His 
 De novo 
  
  
 GEN587R180 
 frameshift_variant 
 c.4038del 
 p.Trp1347GlyfsTer2 
 De novo 
  
  
 GEN587R181 
 splice_region_variant 
 c.4240G>A 
 p.Glu1414Lys 
 De novo 
  
  
 GEN587R182 
 missense_variant 
 c.11266A>T 
 p.Lys3756Ter 
 De novo 
  
  
 GEN587R183 
 splice_site_variant 
 c.222+1G>T 
  
 De novo 
  
 Simplex 
 GEN587R184 
 frameshift_variant 
 c.3632_3633del 
 p.Ile1211ArgfsTer40 
 De novo 
  
  
 GEN587R185 
 splice_site_variant 
 c.2797-1G>A 
  
 De novo 
  
  
 GEN587R186 
 stop_gained 
 c.922C>T 
 p.Gln308Ter 
 De novo 
  
  
 GEN587R187 
 copy_number_loss 
  
  
 Unknown 
  
  
 GEN587R188 
 splice_site_variant 
 c.2179-1G>A 
  
 De novo 
  
  
 GEN587R189 
 stop_gained 
 c.3019C>T 
 p.Arg1007Ter 
 De novo 
  
  
 GEN587R190 
 copy_number_loss 
  
  
 De novo 
  
  
 GEN587R191 
 frameshift_variant 
 c.1046_1047del 
 p.His349ArgfsTer91 
 De novo 
  
  
 GEN587R192 
 frameshift_variant 
 c.4400-4986del 
  
 De novo 
  
  
 GEN587R193 
 splice_site_variant 
 c.1288-1G>A 
  
 De novo 
  
  
 GEN587R194 
 stop_gained 
 c.10768G>T 
 p.Glu3590Ter 
 De novo 
  
  
 GEN587R195 
 stop_gained 
 c.862C>T 
 p.His288Tyr 
 De novo 
  
  
 GEN587R196 
 splice_site_variant 
 c.3934_3937del 
 p.Ile1312SerfsTer10 
 De novo 
  
  
 GEN587R197 
 inframe_deletion 
 c.4123_4125del 
 p.Ala1375del 
 De novo 
  
 Simplex 
 GEN587R198 
 stop_gained 
 c.5479C>T 
 p.Gln1827Ter 
 Familial 
 Paternal 
 Multiplex 
 GEN587R199 
 missense_variant 
 c.6311G>C 
 p.Ser2104Thr 
 Familial 
 Maternal 
 Multiplex 
  et al.  

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
4
Duplication
 1
 
4
Duplication
 1
 
4
Deletion-Duplication
 18
 
4
Duplication
 8
 
4
Deletion-Duplication
 12
 

Model Summary

Ank2 null mice exhibit hypoplasia of the corpus callosum, pyramidal tracts and degeneration of the optic nerve.

References

Type
Title
Author, Year
Additional
ANK2 autism mutation targeting giant ankyrin-B promotes axon branching and ectopic connectivity.
Additional
Primary
Nervous system defects of AnkyrinB (-/-) mice suggest functional overlap between the cell adhesion molecule L1 and 440-kD AnkyrinB in premyelinated...

M_ANK2_1_KO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Homozygous ABe22*/* mice, models for human R895* [c.2683C > T], R990* [c.2968C > T] de novo nonsense mutations associated with ASD, have a stop codon inserted into exon 22 producing nonsense-mediated decay in both the 220-kDa and giant ankB polypeptides.
Allele Type: Partial knockout
Strain of Origin: 129SVJ
Genetic Background: C57Bl/6
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_ANK2_1_KO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Heterozygous ABe22*/+ mice, models for human R895* [c.2683C > T], R990* [c.2968C > T] de novo nonsense mutations associated with ASD, have a stop codon inserted into exon 22 producing nonsense-mediated decay and a 50% reduction in both the 220-kDa and giant ankB polypeptides.
Allele Type: Partial knockout
Strain of Origin: 129SVJ
Genetic Background: C57Bl/6
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_ANK2_3_KI_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: A knockin ABe37fs/ was generated using CRISPR to introduce a P2580fs mutation in C57BL/6J mice, similar to the R2608fs human ANK2 de novo frameshift mutation in exon 37 of ANK2 associated with ASD. To minimize the likelihood of off-target excisions from a guide RNA (gRNA) targeting the precise human mutation site since the DNA sequence corresponding to R2608 has similarity with other sites in the mouse genome, P2580, 28 residues away from the actual human site was targeted, since the gRNA for this site had higher genomic selectivity. The frameshift mutation at P2580 was confirmed by DNA seque
Allele Type: Mimic ASD LOF Knockin
Strain of Origin:
Genetic Background: C57BL/6J
ES Cell Line:
Mutant ES Cell Line:
Model Source: C. Guo (Janelia Gene Targeting and Transgenics Resource)

M_ANK2_4_KI_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: A knockin mouse ABe37fs/fs was generated using CRISPR to introduce a P2580fs mutation in C57BL/6J mice, similar to the R2608fs human ANK2 de novo frameshift mutation in exon 37 of ANK2 associated with ASD. To minimize the likelihood of off-target excisions from a guide RNA (gRNA) targeting the precise human mutation site since the DNA sequence corresponding to R2608 has similarity with other sites in the mouse genome, P2580, 28 residues away from the actual human site was targeted, since the gRNA for this site had higher genomic selectivity. The frameshift mutation at P2580 was confirmed by DN
Allele Type: Mimic ASD LOF Knockin
Strain of Origin: C57BL/6J
Genetic Background: C57BL/6J
ES Cell Line:
Mutant ES Cell Line:
Model Source: C. Guo (Janelia Gene Targeting and Transgenics Resource)

M_ANK2_5_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Ank2 conditional knock-out mouse, ABe37f/f; Nestin-Cre mice, where exon 37 of the Ank2 gene was deleted under the control of Nestin-Cre-recombinase, where giant ankB is lost in approximately 90% of neural and glial progenitors.
Allele Type: Conditional (knockout)
Strain of Origin:
Genetic Background: C57BL/6J
ES Cell Line:
Mutant ES Cell Line: 129S6/SvEvTac-derived TL1 ES cells
Model Source: Duke Transgenic Core

M_ANK2_6_KO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: C57BL/6J-background transgenic mice harboring a cassette composed of exon 4 of Ank2 floxed by loxP, along with neomycin-resistance and EGFP genes flanked by Flp-Frt (Ank2fl/fl mice), were generated by Biocytogen. To generate floxed heterozygous mice (Ank2fl/+), the cassette was removed by crossing Ank2fl/fl mice with protamine-Flp mice (C57BL/6J). To generate Ank2 global knockout (KO) mice, fertilized eggs were treated at the two-cell embryo stage with purified HTNC, a cell-permeable Cre recombinase (histidine-TAT-nuclear localization-Cre fusion peptide).
Allele Type: Knockout
Strain of Origin: Not specified
Genetic Background: C57BL/6J
ES Cell Line: Not specified
Mutant ES Cell Line:
Model Source: Biocytogen

M_ANK2_7_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: To generate Ank2 conditional knockout (cKO) mice, Ank2fl/+ male mice were crossed with Emx1-Cre female mice (MGI:2684610) to avoid germline transmission of Emx1-Cre. From this mating, Emx1-Cre;Ank2fl/+ female mice were maintained. Ank2fl/+ mice were crossed with each other to produce Ank2fl/fl male mice. Emx1-Cre;Ank2fl/+ female mice were crossed with Ank2fl/fl male mice to produce Ank2fl/fl mice (wildtype controls) and Emx1-Cre;Ank2fl/fl (Ank2-cKO) mice.
Allele Type: Conditional knockout
Strain of Origin: Not specified
Genetic Background: C57BL/6J
ES Cell Line: Not specified
Mutant ES Cell Line:
Model Source: Biocytogen; Jackson

M_ANK2_10_CKO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Ankyrin-B (Ank2) floxed mice with loxP sites flanking exon 24 (MGI:5708349, Peter Mohler) were crossed with Emx1-Cre mice (MGI:2684610), which highly express Cre recombinase at embryonic day 10.5, to generate prenatal deletion of the gene.
Allele Type: Conditional knockout
Strain of Origin: 129/Sv
Genetic Background: B6.129(Cg)*B6.129S2
ES Cell Line: Not specified
Mutant ES Cell Line:
Model Source: Dr. Peter Mohler; Jackson

M_ANK2_11_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Ankyrin-B (Ank2) floxed mice with loxP sites flanking exon 24 (MGI:5708349, Peter Mohler) were crossed with NEX-Cre mice (MGI:2668659), which express Cre recombinase in excitatory neurons in the neocortex and hippocampus, but not inhibitory neurons, during embryonic development.
Allele Type: Conditional knockout
Strain of Origin: 129/Sv
Genetic Background: B6.129(Cg)
ES Cell Line: Not specified
Mutant ES Cell Line:
Model Source: Dr. Peter Mohler; Goebbels et al. 2006 (PMID 17146780)

M_ANK2_12_CKO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Ankyrin-B (Ank2) floxed mice with loxP sites flanking exon 24 (MGI:5708349, Peter Mohler) were crossed with NEX-Cre mice (MGI:2668659), which express Cre recombinase in excitatory neurons in the neocortex and hippocampus, but not inhibitory neurons, during embryonic development.
Allele Type: Conditional knockout
Strain of Origin: 129/Sv
Genetic Background: B6.129(Cg)
ES Cell Line: Not specified
Mutant ES Cell Line:
Model Source: Dr. Peter Mohler; Goebbels et al. 2006 (PMID 17146780)

M_ANK2_8_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Ankyrin-B (Ank2) floxed mice with loxP sites flanking exon 24 (MGI:5708349, Peter Mohler) were crossed with CamK2a-Cre mice (MGI:2177650), which fully express Cre recombinase in the cortex after 4 weeks of age, to generate postnatal deletion of the gene.
Allele Type: Conditional knockout
Strain of Origin: 129/Sv
Genetic Background: B6.129(Cg)*B6.Cg
ES Cell Line: Not specified
Mutant ES Cell Line:
Model Source: Dr. Peter Mohler; Jackson

M_ANK2_9_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Ankyrin-B (Ank2) floxed mice with loxP sites flanking exon 24 (MGI:5708349, Peter Mohler) were crossed with Emx1-Cre mice (MGI:2684610), which highly express Cre recombinase at embryonic day 10.5, to generate prenatal deletion of the gene.
Allele Type: Conditional knockout
Strain of Origin: 129/Sv
Genetic Background: B6.129(Cg)*B6.129S2
ES Cell Line: Not specified
Mutant ES Cell Line:
Model Source: Dr. Peter Mohler; Jackson

M_ANK2_1_KO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity1
Decreased
Description: 2 wk old ank2 null mice that survived were much smaller and showed reduced locomotion owing to size ( data not shown in article)
Exp Paradigm: NA
 General observations
 P14
Mortality/lethality2
Increased
Description: Mutants are born at normal mendelian ratios but do not survive past birth.
Exp Paradigm: NA
 Kaplan-meier survival curve
 0-7 months
Mortality/lethality1
Increased
Description: Ank2 null mice are born in a normal mendelian ratio but 95% of them die early after birth, within pnd 8. all die within first 21 days
Exp Paradigm: NA
 General observations
 P0-p20
Protein modification process1
Decreased
Description: Ank2 null mice have low levels of l1 protein
Exp Paradigm: Specific proteins or protein modifications measured
 Western blot
 P7
Protein modification process1
 No change
 Western blot
 P7
Protein modification process1
 No change
 Western blot
 P7
Brain anatomy1
 No change
 NA
 P0-p3
 Not Reported: Circadian sleep/wake cycle, Communications, Emotion, Immune response, Learning & memory, Maternal behavior, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_ANK2_1_KO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Motor coordination and balance1
Decreased
Description: 2 wk old ank2 null mice that survived were much smaller and showed balance owing to size ( data not shown in article)
Exp Paradigm: NA
 General observations
 P14
Anatomical projections and connectivity1
Increased
Description: There is increase in axon fasciculation in ank2 null mice. many axons have increased diameter and contain multivescicular bodies.
Exp Paradigm: NA
 Electron microscopy
 P1
Anatomical projections and connectivity1
Decreased
Description: Ank2 null mice have reduced and poorly defined internal capsule
Exp Paradigm: NA
 Diffusion weighted magnetic resonance imaging (dwi)
 P1-p5
Anatomical projections and connectivity1
Decreased
Description: Ank2 null mice have reduced staining of l1 protein in the pyramidal tract and lateral columns of spinal cord
Exp Paradigm: NA
 Immunohistochemistry
 P7
Anatomical projections and connectivity1
Decreased
Description: Ank2 mice have reduced staining of l1 in the optic nerve
Exp Paradigm: NA
 Immunohistochemistry
 P7
Morphology and size of the corpus callosum1
Decreased
Description: Ank2 null mice have a greatly reduced corpus callosum with a nearly complete absence of the anterior portion
Exp Paradigm: NA
 Diffusion weighted magnetic resonance imaging (dwi)
 P1-p5
Anatomical projections and connectivity1
Decreased
Description: Ank2 null mice have reduced staining of l1 protein in premyelinated axon tracts in fimbria and fornix
Exp Paradigm: NA
 Immunohistochemistry
 P7
Anatomical projections and connectivity1
Decreased
Description: Ank2 mice have an almost complete degeneration of the optic nerve by 20 days of age
Exp Paradigm: NA
 Immunohistochemistry
 P20
Brain anatomy1
Increased
Description: Ank2 null mice have a significantly increased volume of the lateral ventricles (seven fold)
Exp Paradigm: NA
 NA
 P0-p3
Anatomical projections and connectivity1
Decreased
Description: Ank2 null mice have reduced and poorly defined pyramidal tracts
Exp Paradigm: NA
 Diffusion weighted magnetic resonance imaging (dwi)
 P1-p5
Olfaction2
Abnormal
Description: Mutants show no change in duration spent in the urine area or in the latency to enter the urine area.
Exp Paradigm: NA
 Scent marking test
 Adult
Social scent marking or recognition2
Decreased
Description: Mutants show fewer territory markings around urine from an estrous female.
Exp Paradigm: NA
 Scent marking test
 Adult
Reproductive function2
Abnormal
Description: Mutants show no change in fertility.
Exp Paradigm: NA
 Kaplan-meier survival curve
 Adult
Size/growth1
Decreased
Description: Ank2 null mice that survive till 2 weeks of age weigh about 25% of the control littermates.
Exp Paradigm: NA
 General observations
 P14
Mortality/lethality2
Abnormal
Description: Mutants are born at normal mendelian ratios and show no change in lifespan.
Exp Paradigm: NA
 Kaplan-meier survival curve
 0-7 months
Size/growth2
Abnormal
Description: Mutants show no change in body weight.
Exp Paradigm: NA
 Body weight measurement
 Adult
Cognitive flexibility2
Abnormal
Description: Mutants show no change in errors made during the reversal trial in reaching the hidden platform during the first trial.
Exp Paradigm: NA
 Water t-maze test
 Adult
Targeted expression2
Decreased
Description: Mutants show decreased expression of both the 440kda and 220kda ankb proteins.
Exp Paradigm: NA
 Western blot
 Not reported
Spatial learning2
 No change
 Water t-maze test
 Adult
Brain anatomy1
 No change
 NA
 Unreported
Brain anatomy1
 No change
 NA
 Unreported
 Not Reported: Circadian sleep/wake cycle, Communications, Emotion, Immune response, Learning & memory, Maternal behavior, Molecular profile, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_ANK2_3_KI_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Synapse density: excitatory1
Increased
Description: Mutants show increase in vglut2 positive excitatory synapses in the somatosensory cortex.
Exp Paradigm: Somatosensory cortex
 Immunofluorescence staining
 3 weeks
Synapse density1
Increased
Description: Mutants show increase in presynaptic puncta identified by synaptophysin in the somatosensory cortex.
Exp Paradigm: Somatosensory cortex
 Immunofluorescence staining
 3 weeks
Dendritic architecture: spine density1
Increased
Description: Mutants show increase in pyramidal neuron dendritic spines in the somatosensory cortex.
Exp Paradigm: Somatosensory cortex
 Immunofluorescence staining
 3 weeks
Social scent marking or recognition1
Decreased
Description: Mutants show fewer territory markings around urine from an estrous female.
Exp Paradigm: NA
 Scent marking test
 Adult
Ultrasonic vocalization: isolation induced1
Decreased
Description: Mutants emitted fewer usvs.
Exp Paradigm: NA
 Monitoring ultrasonic vocalizations
 P7
Cognitive flexibility1
Increased
Description: Mutants made fewer errors and had greater success in reaching the hidden platform during the first trial.
Exp Paradigm: NA
 Water t-maze test
 Adult
Targeted expression1
Decreased
Description: Mutants show no expression of 440kda ankb but express a truncated 290kda ankb and normal levels of 220kda ankb.
Exp Paradigm: NA
 Western blot
 Not reported
Mortality/lethality1
 No change
 Kaplan-meier survival curve
 0-7 months
Size/growth1
 No change
 Body weight measurement
 Adult
Spatial learning1
 No change
 Water t-maze test
 Adult
Axonal architecture: branch number1
 No change
 Immunofluorescence staining
 3 weeks
Dendritic architecture: spine density1
 No change
 Immunofluorescence staining
 2 months
Synapse density1
 No change
 Immunofluorescence staining
 2 months
Synapse density: excitatory1
 No change
 Immunofluorescence staining
 2 months
Synapse density: inhibitory1
 No change
 Immunofluorescence staining
 3 weeks, 2 months
Reproductive function1
 No change
 Kaplan-meier survival curve
 Adult
Olfaction1
 No change
 Scent marking test
 Adult
 Not Reported:

M_ANK2_4_KI_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity: ambulatory activity1
Decreased
Description: Mutants show decrease in total distance traveled.
Exp Paradigm: NA
 Open field test
 Adult
Self grooming: artificial stress evoked1
Increased
Description: Mutants show increase in self grooming after being misted.
Exp Paradigm: NA
 Grooming behavior assessments
 Adult
Synapse density: excitatory1
Increased
Description: Mutants show increase in vglut2 positive excitatory synapses in the somatosensory cortex.
Exp Paradigm: Somatosensory cortex
 Immunofluorescence staining
 3 weeks
Dendritic architecture: spine density1
Increased
Description: Mutants show increase in pyramidal neuron dendritic spines in the somatosensory cortex.
Exp Paradigm: Somatosensory cortex
 Immunofluorescence staining
 3 weeks
Synapse density1
Increased
Description: Mutants show increase in presynaptic puncta identified by synaptophysin in the somatosensory cortex.
Exp Paradigm: Somatosensory cortex
 Immunofluorescence staining
 3 weeks
Anatomical projections and connectivity1
Increased
Description: Mutant cortices show increase in interhemispheric asymmetry of long tracks. mutants show small differences in asymmetry in the whole brain that are not statistically significant.
Exp Paradigm: Interhemispheric track asymmetry was assayed for either the entire brain or for the cerebral cortex by performing voxel-based comparisons within hemispheres of individual mice
 Diffusion tensor imaging
 3 weeks
Neuronal morphology: axonal structure1
Abnormal
Description: Mutants show unmyelinated axon shafts in the corpus callosum with microtubules arranged in a broad, low amplitude peak shifted 40 to 50nm from the cell membrane whereas control axons show a cortical microtubule population centered around 20 to 30 nm from the plasma membrane. mutants show no change in the number of microtubules in the axons.
Exp Paradigm: Corpus callosum
 Electron microscopy
 3 weeks
Synapse density: excitatory1
Increased
Description: Mutants show no change in vglut2 positive excitatory synapses in the somatosensory cortex.
Exp Paradigm: Somatosensory cortex
 Immunofluorescence staining
 2 months
Dti: fractional anisotropy or relative anisotropy in brain regions1
Increased
Description: Mutants show small but significant increases in connectivity using fractional anisotropy.
Exp Paradigm: Whole brain; whole brain pair-wise connectivity of white matter tracks was measured using fractional anisotropy in an atlas of 332 brain regions from the dti images
 Diffusion tensor imaging
 3 weeks
Miniature post synaptic current amplitude: excitatory1
Increased
Description: Mutants show increase in mepsc amplitude.
Exp Paradigm: Somatosensory cortex
 Whole-cell patch clamp
 3 weeks
Presynaptic function: paired-pulse facilitation1
Decreased
Description: Mutants show less facilitation of the second epsc.
Exp Paradigm: Somatosensory cortex
 Whole-cell patch clamp
 3 weeks
Action potential property: firing rate1
Increased
Description: Mutants show increase in action potential firing rate.
Exp Paradigm: Somatosensory cortex
 Whole-cell patch clamp
 3 weeks
Miniature post synaptic current frequency: excitatory1
Increased
Description: Mutants show increase in mepsc frequency.
Exp Paradigm: Somatosensory cortex
 Whole-cell patch clamp
 3 weeks
Miniature post synaptic current frequency: excitatory1
Decreased
Description: Mutants show decrease in mepsc frequency.
Exp Paradigm: Somatosensory cortex
 Whole-cell patch clamp
 2 months
Social scent marking or recognition1
Decreased
Description: Mutants show fewer territory markings around urine from an estrous female.
Exp Paradigm: NA
 Scent marking test
 Adult
Ultrasonic vocalization: isolation induced1
Decreased
Description: Mutants emitted fewer usvs.
Exp Paradigm: NA
 Monitoring ultrasonic vocalizations
 P7
Cognitive flexibility1
Increased
Description: Mutants made fewer errors and had greater success in reaching the hidden platform during the first trial.
Exp Paradigm: NA
 Water t-maze test
 Adult
Targeted expression1
Decreased
Description: Mutants show no expression of 440kda ankb but express a truncated 290kda ankb at half the level of 440kda ankb and normal levels of 220kda ankb.
Exp Paradigm: NA
 Western blot
 Not reported
Protein expression: in situ protein expression1
Decreased
Description: Mutants show decrease in the expression levels of l1cam in the corpus callosum.
Exp Paradigm: Corpus callosum.
 Immunofluorescence staining
 Adult
Protein binding1
Decreased
Description: Mutants show lower intensity of signal for in situ proximity of l1cam and 220kda ankb or 440kda ankb along the axon tracts of the corpus callosum. mutants show lower intensity of signal for in situ proximity of l1cam and 290kda truncated ankb along the axon tracts of the corpus callosum.
Exp Paradigm: Corpus callosum
 Proximity ligation assay
 Adult
Mortality/lethality1
 No change
 Kaplan-meier survival curve
 0-7 months
Size/growth1
 No change
 Body weight measurement
 Adult
Anxiety1
 No change
 Light-dark exploration test
 Adult
Cognitive flexibility1
 No change
 Morris water maze test
 Adult
Object recognition memory1
 No change
 Novel object recognition test
 Adult
Spatial learning1
 No change
 Morris water maze test
 Adult
Spatial learning1
 No change
 Water t-maze test
 Adult
Protein expression level evidence1
 No change
 Western blot
 Adult
Protein expression: in situ protein expression1
 No change
 Immunofluorescence staining
 Adult
Motor coordination and balance1
 No change
 Accelerating rotarod test
 Adult
Anatomical projections and connectivity1
 No change
 Histology
 3 weeks
Axonal architecture: branch number1
 No change
 Immunofluorescence staining
 3 weeks
Brain size1
 No change
 Diffusion tensor imaging
 3 weeks
Dendritic architecture: spine density1
 No change
 Immunofluorescence staining
 2 months
Synapse density1
 No change
 Immunofluorescence staining
 2 months
Synapse density: inhibitory1
 No change
 Immunofluorescence staining
 3 weeks, 2 months
Action potential property: firing rate1
 No change
 Whole-cell patch clamp
 2 months
Miniature post synaptic current amplitude: excitatory1
 No change
 Whole-cell patch clamp
 2 months
Miniature post synaptic current amplitude: inhibitory1
 No change
 Whole-cell patch clamp
 3 weeks, 2 months
Miniature post synaptic current frequency: inhibitory1
 No change
 Whole-cell patch clamp
 3 weeks, 2 months
Presynaptic function: paired-pulse facilitation1
 No change
 Whole-cell patch clamp
 2 months
Reproductive function1
 No change
 Kaplan-meier survival curve
 Adult
Seizures1
 No change
 Whole-cell patch clamp
 Not reported
Olfaction1
 No change
 Scent marking test
 Adult
Rearing behavior1
 No change
 Open field test
 Adult
 Not Reported:

M_ANK2_5_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Social scent marking or recognition1
Decreased
Description: Mutants show fewer territory markings around urine from an estrous female.
Exp Paradigm: NA
 Scent marking test
 Adult
Ultrasonic vocalization: isolation induced1
Decreased
Description: Mutants emitted fewer usvs.
Exp Paradigm: NA
 Monitoring ultrasonic vocalizations
 P7
Cognitive flexibility1
Increased
Description: Mutants made fewer errors and had greater success in reaching the hidden platform during the first trial.
Exp Paradigm: NA
 Water t-maze test
 Adult
Targeted expression1
Decreased
Description: Mutants show no expression of 440kda ankb in the corpus callossum.
Exp Paradigm: Corpus callossum
 Immunofluorescence staining
 Adult
Targeted expression1
Abnormal
Description: Mutants do not express the 440kda or truncated 290kda ankb but show increased expression of the 220kda ankb.
Exp Paradigm: NA
 Western blot
 Adult
Protein binding1
Decreased
Description: Mutants show lower intensity of signal for in situ proximity of l1cam and 220kda ankb or 440kda ankb along the axon tracts of the corpus callosum. mutants show lower intensity of signal for in situ proximity of l1cam and 290kda truncated ankb along the axon tracts of the corpus callosum.
Exp Paradigm: NA
 Proximity ligation assay
 Adult
Mortality/lethality1
 No change
 Kaplan-meier survival curve
 0-7 months
Size/growth1
 No change
 Body weight measurement
 Adult
Spatial learning1
 No change
 Water t-maze test
 Adult
Reproductive function1
 No change
 Kaplan-meier survival curve
 Adult
Olfaction1
 No change
 Scent marking test
 Adult
 Not Reported:

M_ANK2_6_KO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Self grooming1
Decreased
Description: Heterozygous female mutants show decreased seff grooming behavior, measured in a novel home cage environment.
 Novel cage test
 2-3 months
Startle response: acoustic stimulus1
Decreased
Description: Heterozygous male mutants show a decreased startle response to an acoustic stimulus.
 Acoustic startle reflex test
 2-3 months
Anxiety1
Increased
Description: Heterozygous male mutants show increased anxiety behavior, measured by reduced time spent in the center of the open field.
 Open field test
 2-3 months
Targeted expression1
Decreased
Description: Heterozygous mutants show decrease of both long and short variants of Ankyrin-B in total lysate from whole brain, with about 40-50% protein levels for the short variant, and 50-60% levels of the long variant, compared to wildtype.
 Western blot
 8 weeks
Ultrasonic vocalization: interaction induced: opposite sex stimulus1
 No change
 Monitoring ultrasonic vocalizations
 2-3 months
Anxiety1
 No change
 Open field test
 2-3 months
Anxiety1
 No change
 Light-dark exploration test
 2-3 months
Anxiety1
 No change
 Elevated plus maze test
 2-3 months
Cognitive flexibility1
 No change
 Morris water maze test
 2-3 months
Cued or contextual fear conditioning: memory of context1
 No change
 Fear conditioning test
 2-3 months
Spatial learning1
 No change
 Morris water maze test
 2-3 months
Spatial reference memory1
 No change
 Morris water maze test
 2-3 months
General locomotor activity: ambulatory activity1
 No change
 Open field test
 2-3 months
Motor coordination and balance1
 No change
 Accelerating rotarod test
 2-3 months
Repetitive digging1
 No change
 Novel cage test
 2-3 months
Repetitive nose pokes1
 No change
 Hole-board test
 2-3 months
Self grooming1
 No change
 Novel cage test
 2-3 months
Sensorimotor gating1
 No change
 Prepulse inhibition
 2-3 months
Startle response: acoustic stimulus1
 No change
 Acoustic startle reflex test
 2-3 months
Social approach1
 No change
 Three-chamber social approach test
 2-3 months
Social memory1
 No change
 Three-chamber social approach test
 2-3 months
 Not Reported:

M_ANK2_7_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity: ambulatory activity1
Increased
Description: Conditional knockouts show increased ambulatory activity, measured by total distance moved in the open field test.
 Open field test
 3-4 weeks
General locomotor activity: ambulatory activity1
Increased
Description: Conditional knockouts show increased ambulatory activity, measured by total distance moved in a novel home cage environment.
Exp Paradigm: Novel home cage, behavior measured for 10 minutes after a 10-minute habituation.
 Novel cage test
 3-4 weeks
Action potential property: firing rate1
Increased
Description: Conditional knockouts show increased mean firing rate in the somatosensory cortex, layer 2/3 and layer 5, as well as increased mean burst rate in later 2/3. There is also a trend for increased local field potential frequency in layer 2/3.
Exp Paradigm: Multielectrode array
 Field potential recordings
 3 weeks
Ion efflux and permeability: potassium ions1
Decreased
Description: Neurons in conditional knockouts are less susceptible to potassium voltage-gated channel Kv7.2/3 antagonist.
 Whole-cell patch clamp
 3 weeks
Action potential property: after hyperpolarization1
Decreased
Description: Conditional knockouts show a decrease in the medium after hyperpolarization after a sustained action potential.
 Whole-cell patch clamp
 3 weeks
Intrinsic membrane properties1
Abnormal
Description: Conditional knockouts show increased input resistance.
 Whole-cell patch clamp
 3 weeks
Epsp-spike relationship1
Increased
Description: Conditional knockouts show an increase in the current-firing curve slope for layer 2/3 neurons.
 Whole-cell patch clamp
 3 weeks
Miniature post synaptic current amplitude: inhibitory1
Decreased
Description: Conditional knockouts show a decrease in mIPSC amplitude.
 Whole-cell patch clamp
 3 weeks
Self grooming1
Decreased
Description: Conditional knockouts show decreased self grooming in a novel home cage environment.
Exp Paradigm: Novel home cage, behavior measured for 10 minutes after a 10-minute habituation.
 Novel cage test
 3-4 weeks
Repetitive digging1
Decreased
Description: Conditional knockouts show decreased digging behavior in a novel home cage environment.
Exp Paradigm: Novel home cage, behavior measured for 10 minutes after a 10-minute habituation.
 Novel cage test
 3-4 weeks
Seizure threshold1
Decreased
Description: Conditional knockouts show a reduced threshold to reach stage 2 and stage 3 seizures in response to pentylenetetrazole.
 Observation of chemically induced seizures
 3-4 weeks
Seizures1
Increased
Description: Conditional knockouts show increased chemically induced seizures, with reduced latency to seizure, greater percentage of animals showing seizures, and higher frequency and duration of stage 2 seizures.
 Observation of chemically induced seizures
 3-4 weeks
Seizures1
Increased
Description: Conditional knockouts exhibit spontaneous seizures, measured by EEG showing epileptiform spike discharges.
 Observation of seizures
 3-8 weeks
Social memory1
Decreased
Description: Conditional knockouts show decreased social memory, measured by a lack of preference for a novel social stimulus over a familiar social stimulus.
 Three-chamber social approach test
 3-4 weeks
Juvenile play1
Increased
Description: Conditional knockouts show increased juvenile play behavior, measured by increased nose-to-nose and nose-to-body sniffing behavior.
 Reciprocal social interaction test
 3-4 weeks
Mortality/lethality: life span1
Decreased
Description: Conditional knockouts show a reduced lifespan due to spontaneous seizures, with death between P20 and P50.
 Survival analysis
 P0-P60
Anxiety1
Decreased
Description: Conditional knockouts show decreased anxiety behavior, measured by increased time spent and increased number of entries to light chamber in light-dark exploration test.
 Light-dark exploration test
 3-4 weeks
Anxiety1
Increased
Description: Conditional knockouts show increased anxiety behavior, measured by decreased time in center of open field.
 Open field test
 3-4 weeks
Anxiety1
Decreased
Description: Conditional knockouts show decreased anxiety behavior, measured by increased time spent and number of entries into open arms of the elevated plus maze test.
 Elevated plus maze test
 3-4 weeks
Protein expression: in situ protein expression1
Increased
Description: Ankyrin-B conditional knockouts show an increase in Ank3 protein expression in the somatosensory cortex layer 2/3.
 Immunohistochemistry
 3 weeks
Targeted expression1
Decreased
Description: Conditional knockouts show decreased expression of both long and short variants of Ankyrin-B in total lysates and, in synaptosomal fractions from cortex and hippocampus, with 10% of wildtype levels for the short variant and 20% of wildtype levels for the long variant.
Exp Paradigm: Fractionation
 Western blot
 3 weeks
Protein expression level evidence1
Decreased
Description: Conditional knockouts show decreased levels of voltage-gated potassium channels Kv7.2 and Kv7.3 in total lysates and synaptosomal fraction of cortex and hippocampus. Conditional knockouts also show decreased levels of voltage-gated sodium channels Nav1.2 and Nav1.6 in total lysates from cortex and hippocampus, but not significantly decreased levels in synaptosomal fraction.
Exp Paradigm: Kv7.2, Kv7.3, NaV1.2, NaV1.6
 Western blot
 3 weeks
Proteomic profile diversity1
Abnormal
Description: Synaptosomal fraction from cortex and hippocampus, total lysate
 Liquid chromatography-mass spectrometry (LC-MS)
 3 weeks
Protein modification process1
Abnormal
Description: Conditional knockouts show proteins with downregulated and proteins with upregulated post-translational modifications. Specifically, potassium voltage-gated channels show downregulation of post-translational modifications.
 Liquid chromatography-mass spectrometry (LC-MS)
 3 weeks
Myelination: node of Ranvier morphology1
 No change
 Immunohistochemistry
 3 weeks
Size/growth1
 No change
 Body weight measurement
 2-8 weeks
Neuroreceptor levels: GABA-R: GABAA1
 No change
 Western blot
 3 weeks
Action potential property: amplitude1
 No change
 Whole-cell patch clamp
 3 weeks
Action potential property: half-width1
 No change
 Whole-cell patch clamp
 3 weeks
Action potential property: rate of depolarization1
 No change
 Whole-cell patch clamp
 3 weeks
Action potential property: rate of repolarization1
 No change
 Whole-cell patch clamp
 3 weeks
Action potential property: threshold1
 No change
 Whole-cell patch clamp
 3 weeks
Intrinsic bursting events or spikes1
 No change
 Field potential recordings
 3 weeks
Local field potential1
 No change
 Field potential recordings
 3 weeks
Membrane potential1
 No change
 Whole-cell patch clamp
 3 weeks
Miniature post synaptic current amplitude: excitatory1
 No change
 Whole-cell patch clamp
 3 weeks
Miniature post synaptic current frequency: excitatory1
 No change
 Whole-cell patch clamp
 3 weeks
Miniature post synaptic current frequency: inhibitory1
 No change
 Whole-cell patch clamp
 3 weeks
Spontaneous post synaptic event amplitude: excitatory currents1
 No change
 Whole-cell patch clamp
 3 weeks
Spontaneous post synaptic event amplitude: inhibitory currents1
 No change
 Whole-cell patch clamp
 3 weeks
Spontaneous post synaptic event frequency: excitatory currents1
 No change
 Whole-cell patch clamp
 3 weeks
Spontaneous post synaptic event frequency: inhibitory currents1
 No change
 Whole-cell patch clamp
 3 weeks
Tonic currents through extrasynaptic receptors1
 No change
 Whole-cell patch clamp
 3 weeks
Vertical jumping or back flipping1
 No change
 Novel cage test
 3-4 weeks
Social approach1
 No change
 Three-chamber social approach test
 3-4 weeks
 Not Reported:

M_ANK2_10_CKO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Ultrasonic vocalization: isolation induced1
 No change
 Monitoring ultrasonic vocalizations
 P7
Mortality/lethality: life span1
 No change
 Survival analysis
 P0-P140
Size/growth1
 No change
 Body weight measurement
 4 weeks
Anxiety1
 No change
 Elevated zero maze test
 4-14 weeks
Anxiety1
 No change
 Light-dark exploration test
 4-14 weeks
Depression1
 No change
 Forced swim test
 4-14 weeks
Spatial working memory1
 No change
 Y-maze test
 4-14 weeks
General locomotor activity: ambulatory activity1
 No change
 Open field test
 4-14 weeks
Social approach1
 No change
 Three-chamber social approach test
 4-14 weeks
Social memory1
 No change
 Three-chamber social approach test
 4-14 weeks
 Not Reported:

M_ANK2_11_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Mortality/lethality: life span1
Increased
Description: NEX-driven knockout mice, with prenatal deletion of Ank2 in excitatory neurons, exhibit spontaneous seizures, which lead to an early lethality, similar to Emx-driven knockout mice.
 Survival analysis
 P0-P140
 Not Reported:

M_ANK2_12_CKO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Mortality/lethality: life span1
 No change
 Survival analysis
 P0-P140
 Not Reported:

M_ANK2_8_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Targeted expression1
Decreased
Description: Western blotting of cortical homogenates show Ankyrin-B protein levels are sharply reduced when Cre is expressed.
 Western blot
 unreported
Mortality/lethality: life span1
 No change
 Survival analysis
 P0-P140
Size/growth1
 No change
 Body weight measurement
 14 weeks
Anxiety1
 No change
 Elevated zero maze test
 4-14 weeks
Anxiety1
 No change
 Light-dark exploration test
 4-14 weeks
Depression1
 No change
 Forced swim test
 4-14 weeks
Spatial working memory1
 No change
 Y-maze test
 4-14 weeks
General locomotor activity: ambulatory activity1
 No change
 Open field test
 4-14 weeks
Social approach1
 No change
 Three-chamber social approach test
 4-14 weeks
Social memory1
 No change
 Three-chamber social approach test
 4-14 weeks
 Not Reported:

M_ANK2_9_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity: ambulatory activity1
Increased
Description: Conditional knockouts with prenatal deletion of Ank2 show enhanced locomotor activity in the open field test.
 Open field test
 4-14 weeks
Action potential property: amplitude1
Increased
Description: Acute brain slices from the conditional knockouts with prenatal deletion of Ank2 show increased calcium event amplitude in layers 2/3 somatosensory cortex.
 Calcium imaging
 2 weeks
Network excitability1
Increased
Description: Acute brain slices from the conditional knockouts with prenatal deletion of Ank2 show increased frequency of network events.
 Calcium imaging
 2 weeks
Action potential property: half-width1
Decreased
Description: Acute brain slices from the conditional knockouts with prenatal deletion of Ank2 show decreased calcium event half-width in layers 2/3 somatosensory cortex.
 Calcium imaging
 2 weeks
Action potential property: firing rate1
Increased
Description: Acute brain slices from the conditional knockouts with prenatal deletion of Ank2 show increased calcium event frequency in layers 2/3 somatosensory cortex.
 Calcium imaging
 2 weeks
Seizures1
Increased
Description: Conditional knockouts with prenatal deletion of Ank2 show spontaneous seizures, with a frequency of approximately 2 seizures per hour, and a duration of approximately 50 seconds per seizure, starting at age P20.
 Observation of seizures
 P0-P70
Seizures1
Increased
Description: Conditional knockouts with prenatal deletion of Ank2 show spontaneous seizures, and died between 12 hours and 5 days from seizure onset.
 Survival analysis
 P0-P70
Social memory1
Decreased
Description: Conditional knockout male mice with prenatal deletion of Ank2 show decreased preference for novel social stimulus.
 Three-chamber social approach test
 4-14 weeks
Mortality/lethality: life span1
Increased
Description: Emx-driven knockout mice, with prenatal deletion of Ank2, exhibit spontaneous seizures starting at about P20. Spontaneous seizures in conditional knockout mice lead to 50% lethality at age P36 and 100% lethality at 9 months of age.
 Survival analysis
 P0-P140
Protein localization: synapse1
Abnormal
Description: Conditional knockouts with prenatal deletion of Ank2 show increased expression of Kalrn, and reduced expression of RPS4X in synaptosomal fraction.
Exp Paradigm: Kalrn, RPS4X
 Western blot
 2 weeks
Targeted expression1
Decreased
Description: Western blotting of cortical homogenates show Ankyrin-B protein levels are sharply reduced when Cre is expressed. Ankyrin-B levels are specifically reduced in the synaptosomal fraction as well.
 Western blot
 unreported
Proteomic profile diversity1
Abnormal
Description: Conditional knockouts with prenatal deletion of Ank2 show upregulation and downregulation of protein expression.
 Liquid chromatography-mass spectrometry (LC-MS)
 2 weeks
Ultrasonic vocalization: isolation induced1
 No change
 Monitoring ultrasonic vocalizations
 P7
Size/growth1
 No change
 Body weight measurement
 4 weeks
Anxiety1
 No change
 Elevated zero maze test
 4-14 weeks
Anxiety1
 No change
 Light-dark exploration test
 4-14 weeks
Depression1
 No change
 Forced swim test
 4-14 weeks
Spatial working memory1
 No change
 Y-maze test
 4-14 weeks
Neuroreceptor levels: glutamate receptors: ampa receptors1
 No change
 Western blot
 2 weeks
Social approach1
 No change
 Three-chamber social approach test
 4-14 weeks
Social memory1
 No change
 Three-chamber social approach test
 4-14 weeks
 Not Reported:


Interactor Symbol Interactor Name Interactor Organism Entrez ID Uniprot ID Interaction Type Evidence Reference
ACOT7 acyl-CoA thioesterase 7 11332 O00154 IP; LC-MS/MS; IP/WB
Li J , et al. 2016
C14ORF104 Protein kintoun 55172 Q9NVR5-2 IP; LC-MS/MS
Huttlin EL , et al. 2015
CCT2 chaperonin containing TCP1, subunit 2 (beta) 10576 P78371 IP; LC-MS/MS
Li J , et al. 2016
CHL1 cell adhesion molecule with homology to L1CAM (close homolog of L1) 10752 O00533 IP; LC-MS/MS
Huttlin EL , et al. 2015
CRNKL1 crooked neck pre-mRNA splicing factor-like 1 (Drosophila) 51340 Q9BZJ0 IP; LC-MS/MS
Li J , et al. 2016
DGUOK deoxyguanosine kinase 1716 E5KSL5 IP; LC-MS/MS
Huttlin EL , et al. 2015
DMD dystrophin 1756 P11532 in vitro binding assay
Ayalon G , et al. 2008
DNAJB1 DnaJ (Hsp40) homolog, subfamily B, member 1 3337 P25685 GST; Y2H; IP/WB
Mohler PJ , et al. 2004
EPB42 erythrocyte membrane protein band 4.2 2038 P16452 Reconstituted complex
Korsgren C and Cohen CM 1988
FARP1 FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) 10160 Q9Y4F1 IP; LC-MS/MS
Li J , et al. 2016
FTSJ3 FtsJ homolog 3 (E. coli) 117246 Q8IY81 IP; LC-MS/MS
Li J , et al. 2016
HAX1 HCLS1 associated protein X-1 10456 O00165 IP; LC-MS/MS
Huttlin EL , et al. 2015
HIF1AN hypoxia inducible factor 1, alpha subunit inhibitor 55662 Q9NWT6 IP; LC-MS/MS
Huttlin EL , et al. 2015
KIAA0368 KIAA0368 23392 J3KN16 Y2H; LC-MS/MS
Gorbea C , et al. 2010
MAPK8IP1 mitogen-activated protein kinase 8 interacting protein 1 9479 Q6NUQ9 IP; LC-MS/MS
Huttlin EL , et al. 2015
MYO1D myosin ID 4642 O94832 IP; LC-MS/MS
Li J , et al. 2016
NDEL1 nudE nuclear distribution E homolog (A. nidulans)-like 1 81565 Q9GZM8 Y2H
Camargo LM , et al. 2006
NUFIP1 Nuclear FMRP Interacting Protein 1 26747 Q9UHK0 IP; LC-MS/MS
Huttlin EL , et al. 2015
OBSCN obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF 84033 Q5VST9 GST; IP/WB
Bagnato P , et al. 2003
PALM2 paralemmin 2 114299 Q8IXS6 IP; LC-MS/MS
Huttlin EL , et al. 2015
RAPGEF5 Rap guanine nucleotide exchange factor (GEF) 5 9771 A8MQ07 IP; LC-MS/MS
Huttlin EL , et al. 2015
SPTBN1 spectrin, beta, non-erythrocytic 1 6711 Q01082 Y2H; IP/WB
Mohler PJ , et al. 2004
TAF9 TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa 6880 Q16594 Y2H; IP/WB
Miyamoto-Sato E , et al. 2010
TNIK TRAF2 and NCK interacting kinase 23043 Q9UKE5 Y2H
Camargo LM , et al. 2006
TP53 tumor protein p53 7157 P04637 Y2H; IP/WB
Miyamoto-Sato E , et al. 2010
UBC ubiquitin C 7316 P63279 LC-MS/MS
Danielsen JM , et al. 2010
FMR1 fragile X mental retardation 1 14265 P35922 HITS-CLIP
Darnell JC , et al. 2011
IP3R-3 inositol 1,4,5-trisphosphate receptor, type 3 25679 Q63269 IP/WB
Hayashi T and Su TP 2001
L1CAM L1 cell adhesion molecule 50687 Q05695 IP/WB
Hayashi T and Su TP 2001
SIGMAR1 sigma non-opioid intracellular receptor 1 29336 Q9R0C9 IP/WB
Hayashi T and Su TP 2001
SNCA synuclein, alpha (non A4 component of amyloid precursor) 6622 P37840 LC-MS/MS
McFarland MA , et al. 2008
NFASC neurofascin 116690 P97685 IP/WB
Davis JQ and Bennett V 1994
NRCAM neuronal cell adhesion molecule 497815 Q6PW34 IP/WB
Davis JQ and Bennett V 1994
SLC8A1 solute carrier family 8 (sodium/calcium exchanger), member 1 29715 Q01728 IP/WB
Lencesova L , et al. 2003
SPTAN1 spectrin, alpha, non-erythrocytic 1 64159 P16086 IP/WB
Lencesova L , et al. 2003
SPTB spectrin, beta, erythrocytic 314251 Q6XDA0 IP/WB
Lencesova L , et al. 2003

HELP
Copyright © 2017 MindSpec, Inc.